glp-1 medications zepbound FDA approval for (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and hormone receptors - Eli Lilly Researchers move closer to matching

Its like a little bit a little bit

However, the scientific evidence supporting their role in weight loss is limited

GLP-1 injectables may be considered when you meet BMI criteria (typically 30 or higher, or 27 or higher with weight-related health conditions), you are comfortable with weekly self-injection, and your health profile does not include contraindications for GLP-1 medications

Inform your healthcare provider if you have any existing medical conditions or are taking other medications

secondly, there is a lack of fecal bacteriome transplantation experiments using germ-free mouse models

Are GLP-1s safe for long-term use